Pharma Japan
Subscription Required: Yes
Pharma Japan provides up-to-date news, insights, and analysis on the Japanese pharmaceutical industry, including regulatory changes, market trends, and company developments. LATEST NEWS
- Takeda to Halt Sales of Cell Therapy Alofisel in Japan
- Japan Sets New Pricing Rules for Conditionally Approved Regenerative Medicines, Starting with Elevidys
- Rohto to Roll Out 3- or 4-Day Workweek Option from April to Spur Growth, Retention
- Rakuten Joins Hands with LOTTE Biologics to Boost Production for Photoimmunotherapy
- Japan’s Maternal RSV Vaccine Uptake at 11.6%, Survey Finds
- Daiichi Sankyo Unveils Brand Site for OTC NorLevo Ahead of Launch
- Cheplapharm to Take Over Japan MA for UCB’s Myocalm